What do you get when you combine a top-ranked industry analyst with a retired lieutenant colonel from the U.S. Marine Corp.? You get Steve Brozak, who brings his one-of-a kind perspective on the
The IPO market saw some strong debuts last week with Taylor Morrison Home Corp. (TMHC), Rally Software Development Corp. (RALY), and Chimerix, Inc. (CMRX) enjoying successful first days.In this
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.
| Website: | www.chimerix.com |
| Email: | ir@chimerix.com |
| Main Phone: | +1 919 806-1074 |
| Address: | 2505 Meridian Parkway |
| Address 2: | Suite 100 |
| State: | NC |
| City / Town: | Durham |
| Country: | US |
| Postal Code: | 27713 |
| Exchange: | NSD |
| CEO: | Michael Sherman |
| Employees: | 54 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
What do you get when you combine a top-ranked industry analyst with a retired lieutenant colonel from the U.S. Marine Corp.? You get Steve Brozak, who brings his one-of-a kind perspective on the
The IPO market saw some strong debuts last week with Taylor Morrison Home Corp. (TMHC), Rally Software Development Corp. (RALY), and Chimerix, Inc. (CMRX) enjoying successful first days.In this
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
